Search our extensive Laboratory Test Directory to find test codes, ordering recommendations, specimen stability information, Test Fact Sheets, and more.
Recommendations when to order or not order the test. May include related or preferred tests.
Aids in the diagnosis and monitoring of patients with MPS Type 1 or Type 2.
New York DOH Approval Status
Indicates whether a test has been approved by the New York State Department of Health.
This test is not New York state approved. There are no New York state-approved laboratories available. Submit a Non-Permitted Laboratory Request Form (NPL) to the NYDOH prior to collection of specimen. If NPL is approved by NYDOH, and sample is received at ARUP, testing will be performed.
Specimen Required
Patient PreparationInstructions patient must follow before/during specimen collection.
CollectSpecimen type to collect. May include collection media, tubes, kits, etc.
Lavender (K2EDTA, K3EDTA), Plain Red, or Serum Separator Tube (SST).
Specimen PreparationInstructions for specimen prep before/after collection and prior to transport.
Transfer 500 µL serum or plasma to ARUP Standard transport Tube and freeze immediately. (Min 250 µL)
Storage/Transport TemperaturePreferred temperatures for storage prior to and during shipping to ARUP. See Stability for additional info.
Critical Frozen
Unacceptable ConditionsCommon conditions under which a specimen will be rejected.
Plasma collected in green (heparin) tube. Ambient or Refrigerated Specimens
RemarksAdditional specimen collection, transport, or test submission information.
StabilityAcceptable times/temperatures for specimens. Times include storage and transport time to ARUP.
Expected turnaround time for a result, beginning when ARUP has received the specimen.
14-21 days
Reference Interval
Normal range/expected value(s) for a specific disease state. May also include abnormal ranges.
By report
Interpretive Data
May include disease information, patient result explanation, recommendations, or details of testing.
Total Heparan Sulfate, Serum/Plasma is a sum of the internal disaccharides D0A0 and D0S0. NRE = Non Reducing End
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Compliance Category
Laboratory Developed Test (LDT)
Note
Additional information related to the test.
Hotline History
N/A
CPT Codes
The American Medical Association Current Procedural Terminology (CPT) codes published in ARUP's Laboratory Test Directory are provided for informational purposes only. The codes reflect our interpretation of CPT coding requirements based upon AMA guidelines published annually. CPT codes are provided only as guidance to assist clients with billing. ARUP strongly recommends that clients confirm CPT codes with their Medicare administrative contractor, as requirements may differ. CPT coding is the sole responsibility of the billing party. ARUP Laboratories assumes no responsibility for billing errors due to reliance on the CPT codes published.
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
Other names that describe the test. Synonyms.
MPS 2
MPS I
MPS II
MPS Type 1
MPS 1
Heparan Sulfate total and NRE, Serum/Plasma
HS non reducing end assay
MPS Type 2
Mucopolysaccharidoses Type 1/2, Total Heparan Sulfate and NRE (Sensi-Pro(R)) Quantitative, Serum or Plasma
Connect Sign In
